Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synthetic Genomics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10812
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company provides DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages, among others. It provides solutions in genomics research, bioproduction, applied products, and others. Synthetic Genomics caters to academic and commercial research, development organizations, and others. It also offers production of nutritionals, pharmaceuticals, vaccines and bio-industrial products derived from renewable biological resources, among others. The company operates in partnership with other medical organizations to offer its products. Synthetic Genomics is headquartered in San Diego, California, the US.

Synthetic Genomics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Venture Financing 11
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Partnerships 12
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Licensing Agreements 15
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Equity Offering 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
Asset Transactions 20
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Acquisition 21
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc – Key Competitors 22
Synthetic Genomics Inc – Key Employees 23
Synthetic Genomics Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Corporate Communications 25
Aug 14, 2018: Synthetic Genomics announces changes to its Board of Directors 25
Jun 25, 2018: Synthetic Genomics Names Reinhard J. Ambros As Board Director 26
Government and Public Interest 27
Oct 26, 2017: Synthetic Genomics Partners with Duke Human Vaccine Institute on DARPA Pandemic Prevention Platform Program 27
Product News 28
Aug 22, 2017: BioXp Genomic Workstation Makes European Debut at VIB Research Institute in Belgium 28
Jun 01, 2017: Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis’ Clinical Trials 29
Jan 09, 2017: Synthetic Genomics Launches Vmax Express, a Next-Generation Protein Expression Platform for the Biotech Industry 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthetic Genomics Acquires DNA Technology Patent Portfolio From febit 10
Synthetic Genomics Raises US$10 Million In Venture Financing 11
Janssen Vaccines & Prevention Enters into Research and Licensing Option Agreement with Synthetic Genomics 12
Synthetic Genomics Expands R&D Agreement with Lung Biotech 13
SGI-DNA Enters Into Agreement With Integrated DNA Technologies For Synthetic DNA Products 14
Synthetic Genomics Enters into Licensing Agreement with Arcturus Therapeutics 15
Synthetic Genomics Enters Licensing Agreement with Gen9 for Synthetic Biology Technology Patents 16
New England Biolabs Enters Into Licensing Agreement With Synthetic Genomics 17
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 18
Synthetic Genomics Raises USD50 Million in Private Placement of Shares 19
C3J Therapeutics Acquires Bacteriophage Assets from Synthetic Genomics 20
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 21
Synthetic Genomics Inc, Key Competitors 22
Synthetic Genomics Inc, Key Employees 23
Synthetic Genomics Inc, Subsidiaries 24

List of Figures
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthetic Genomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synthetic Genomics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hyundai Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hyundai Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Prairie Farms Dairy Inc:企業の戦略・SWOT・財務情報
    Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report Summary Prairie Farms Dairy Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fidelity Life Assurance of Zimbabwe Ltd:企業の戦略・SWOT・財務情報
    Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Fidelity Life Assurance of Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Tampa Electric Co:発電所・企業SWOT分析
    Tampa Electric Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Pabst Brewing Company:企業の戦略・SWOT・財務分析
    Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report Summary Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The Medicines Company (MDCO):医療機器:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Episurf Medical AB (EPIS B):企業の財務・戦略的SWOT分析
    Summary Episurf Medical AB (Episurf Medical), formerly Diamorph Medtech AB is a medical technology company that provides patient-specific treatments of painful joint injuries. It offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer …
  • Livzon Pharmaceutical Group Co Ltd (000513):企業の財務・戦略的SWOT分析
    Summary Livzon Pharmaceutical Group Co Ltd (Livzon) a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company which is engaged in developing, manufacturing and distributing pharmaceutical products. The company provides preparation drug products, bulk medicines and in …
  • CRH Medical Corp (CRH):医療機器:M&Aディール及び事業提携情報
    Summary CRH Medical Corp (CRH Medical), formerly Medsurge Medical Products Corp, is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H …
  • Analytica Limited (ALT)-医療機器分野:企業M&A・提携分析
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • Orix Corporation
    Orix Corporation - Strategy, SWOT and Corporate Finance Report Summary Orix Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • ERG Renew SpA:企業の戦略的SWOT分析
    ERG Renew SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Quarterhill Inc.:企業のM&A・事業提携・投資動向
    Quarterhill Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quarterhill Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Koei Tecmo Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Koei Tecmo Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bank Hapoalim Private Banking:企業の戦略・SWOT・財務情報
    Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Japan Pulp and Paper Co Ltd:戦略・SWOT・企業財務分析
    Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Marks and Spencer Group plc:企業の戦略・SWOT・財務分析
    Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report Summary Marks and Spencer Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆